002907 华森制药
已收盘 07-18 15:00:00
资讯
新帖
简况
7月18日华森制药发布公告，股东减持417.58万股
证券之星 · 07-18 19:01
7月18日华森制药发布公告，股东减持417.58万股
7月17日华森制药现1笔折价11.03%的大宗交易 合计成交843.81万元
证券之星 · 07-17 16:59
7月17日华森制药现1笔折价11.03%的大宗交易 合计成交843.81万元
7月16日华森制药现6笔折价13.37%的大宗交易 合计成交3325.08万元
证券之星 · 07-16 16:56
7月16日华森制药现6笔折价13.37%的大宗交易 合计成交3325.08万元
7月14日华森制药现1笔折价10.45%的大宗交易 合计成交204.8万元
证券之星 · 07-14
7月14日华森制药现1笔折价10.45%的大宗交易 合计成交204.8万元
7月11日华森制药现3笔折价11.16%的大宗交易 合计成交603.3万元
证券之星 · 07-11
7月11日华森制药现3笔折价11.16%的大宗交易 合计成交603.3万元
华森制药：7月10日召开分析师会议，安信基金参与
证券之星 · 07-10
华森制药：7月10日召开分析师会议，安信基金参与
7月10日华森制药现3笔折价10.7%的大宗交易 合计成交600.09万元
证券之星 · 07-10
7月10日华森制药现3笔折价10.7%的大宗交易 合计成交600.09万元
华森制药7月8日现2笔大宗交易 总成交金额474.23万元 其中机构买入474.23万元 溢价率为-10.53%
新浪证券-红岸工作室 · 07-08
华森制药7月8日现2笔大宗交易 总成交金额474.23万元 其中机构买入474.23万元 溢价率为-10.53%
华森制药(002907.SZ)：CX001缓释片获得药物临床试验批准
智通财经网 · 07-02
华森制药(002907.SZ)：CX001缓释片获得药物临床试验批准
华森制药7月1日现1笔大宗交易 总成交金额209.86万元 其中机构买入209.86万元 溢价率为-11.41%
新浪证券-红岸工作室 · 07-01
华森制药7月1日现1笔大宗交易 总成交金额209.86万元 其中机构买入209.86万元 溢价率为-11.41%
重庆华森制药股份有限公司药品申请临床试验默示许可获受理
金融界 · 06-30
重庆华森制药股份有限公司药品申请临床试验默示许可获受理
华森制药：6月26日召开分析师会议，上海谦璞投资管理有限公司参与
证券之星 · 06-26
华森制药：6月26日召开分析师会议，上海谦璞投资管理有限公司参与
华森制药收盘上涨1.47%，滚动市盈率90.01倍，总市值69.07亿元
金融界 · 06-24
华森制药收盘上涨1.47%，滚动市盈率90.01倍，总市值69.07亿元
6月23日华森制药现3笔折价10.98%的大宗交易 合计成交650.05万元
证券之星 · 06-23
6月23日华森制药现3笔折价10.98%的大宗交易 合计成交650.05万元
华森制药：6月19日高管彭晓燕减持股份合计3300股
证券之星 · 06-20
华森制药：6月19日高管彭晓燕减持股份合计3300股
6月16日华森制药现1笔折价11.69%的大宗交易 合计成交400.13万元
证券之星 · 06-16
6月16日华森制药现1笔折价11.69%的大宗交易 合计成交400.13万元
6月10日华森制药发布公告，股东减持334.83万股
证券之星 · 06-10
6月10日华森制药发布公告，股东减持334.83万股
6月9日华森制药现2笔折价11%的大宗交易 合计成交501.12万元
证券之星 · 06-09
6月9日华森制药现2笔折价11%的大宗交易 合计成交501.12万元
华森制药收盘下跌6.80%，滚动市盈率98.39倍，总市值75.50亿元
金融界 · 06-06
华森制药收盘下跌6.80%，滚动市盈率98.39倍，总市值75.50亿元
华森制药最新公告：目前经营情况正常 不存在应披露而未披露的重大事项
证券之星 · 06-02
华森制药最新公告：目前经营情况正常 不存在应披露而未披露的重大事项
加载更多
公司概况
公司名称：
重庆华森制药股份有限公司
所属行业：
医药制造业
上市日期：
2017-10-20
主营业务：
重庆华森制药股份有限公司的主营业务是中成药、化学药的研发、生产和销售。公司的主要产品是甘桔冰梅片、都梁软胶囊、六味安神胶囊、八味芪龙颗粒、痛泻宁颗粒、威地美（铝碳酸镁片）、铝碳酸镁咀嚼片、长松（聚乙二醇4000散）、胆舒软胶囊、注射用甲磺酸加贝酯、注射用奥美拉唑钠、上清片、融通（注射用阿魏酸钠）、西洛他唑片、卡托普利片、水王（螺旋藻胶囊）、阿昔洛韦片、甲硝唑片等。
发行价格：
4.53
{"stockData":{"symbol":"002907","market":"SZ","secType":"STK","nameCN":"华森制药","latestPrice":17.36,"timestamp":1752822192000,"preClose":17.4,"halted":0,"volume":13436601,"delay":0,"changeRate":-0.0023,"floatShares":309000000,"shares":418000000,"eps":0.1838,"marketStatus":"已收盘","change":-0.04,"latestTime":"07-18 15:00:00","open":17.26,"high":17.39,"low":16.98,"amount":231000000,"amplitude":0.0236,"askPrice":17.36,"askSize":467,"bidPrice":17.35,"bidSize":308,"shortable":0,"etf":0,"ttmEps":0.1838,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1753061400000},"marketStatusCode":5,"adr":0,"adjPreClose":17.4,"symbolType":"stock","openAndCloseTimeList":[[1752802200000,1752809400000],[1752814800000,1752822000000]],"highLimit":19.14,"lowLimit":15.66,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":417596314,"isCdr":false,"pbRate":4.27,"roa":"--","peRate":94.45049,"roe":"2.4%","epsLYR":0.1837,"committee":-0.550802,"marketValue":7249000000,"turnoverRate":0.0435,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2025-07-21。","floatMarketCap":5362000000},"requestUrl":"/m/hq/s/002907","defaultTab":"news","newsList":[{"id":"2552647884","title":"7月18日华森制药发布公告，股东减持417.58万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2552647884","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552647884?lang=zh_cn&edition=full","pubTime":"2025-07-18 19:01","pubTimestamp":1752836494,"startTime":"0","endTime":"0","summary":"证券之星消息，7月18日华森制药发布公告《华森制药:关于控股股东及其一致行动人持股变动触及1%整数倍的公告》，其股东成都地方建筑机械化工程有限公司于2025年6月26日至2025年7月17日间合计减持417.58万股，占公司目前总股本的1.0%，变动期间该股股价上涨4.88%，截止7月17日收盘报17.4元。股东增减持详情见下表：根据华森制药2025年一季报公布的十大股东详情如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071800031786.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002907"],"gpt_icon":0},{"id":"2552102901","title":"7月17日华森制药现1笔折价11.03%的大宗交易 合计成交843.81万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552102901","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552102901?lang=zh_cn&edition=full","pubTime":"2025-07-17 16:59","pubTimestamp":1752742743,"startTime":"0","endTime":"0","summary":"证券之星消息，7月17日华森制药发生大宗交易，交易数据如下：大宗交易成交价格15.48元，相对当日收盘价折价11.03%，成交54.51万股，成交金额843.81万元，买方营业部为申港证券股份有限公司北京分公司，卖方营业部为华泰证券股份有限公司重庆江北嘴证券营业部。近三个月该股共发生33笔大宗交易，合计成交6.69万手，折价成交33笔。该股近期无解禁股上市。截至2025年7月17日收盘，华森制药报收于17.4元，上涨1.16%，换手率7.03%，成交量21.71万手，成交额3.77亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071700026114.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002907"],"gpt_icon":0},{"id":"2551146489","title":"7月16日华森制药现6笔折价13.37%的大宗交易 合计成交3325.08万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551146489","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551146489?lang=zh_cn&edition=full","pubTime":"2025-07-16 16:56","pubTimestamp":1752656215,"startTime":"0","endTime":"0","summary":"证券之星消息，7月16日华森制药发生大宗交易，交易数据如下：近三个月该股共发生32笔大宗交易，合计成交6.15万手，折价成交32笔。该股近期无解禁股上市。截至2025年7月16日收盘，华森制药(002907)报收于17.2元，上涨3.86%，换手率5.21%，成交量16.09万手，成交额2.73亿元。该股近半年内有股东持股变动，合计净减持1021.56万股，股东增减持明细如下表：该股最近90天内无机构评级。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071600026820.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002907"],"gpt_icon":0},{"id":"2551909483","title":"7月14日华森制药现1笔折价10.45%的大宗交易 合计成交204.8万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2551909483","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551909483?lang=zh_cn&edition=full","pubTime":"2025-07-14 17:01","pubTimestamp":1752483710,"startTime":"0","endTime":"0","summary":"证券之星消息，7月14日华森制药发生大宗交易，交易数据如下：大宗交易成交价格15.17元，相对当日收盘价折价10.45%，成交13.5万股，成交金额204.8万元，买方营业部为机构专用，卖方营业部为华泰证券股份有限公司重庆江北嘴证券营业部。近三个月该股共发生26笔大宗交易，合计成交3.92万手，折价成交26笔。截至2025年7月14日收盘，华森制药报收于16.94元，上涨0.53%，换手率2.61%，成交量8.05万手，成交额1.36亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071400023596.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002907"],"gpt_icon":0},{"id":"2550938055","title":"7月11日华森制药现3笔折价11.16%的大宗交易 合计成交603.3万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550938055","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550938055?lang=zh_cn&edition=full","pubTime":"2025-07-11 16:58","pubTimestamp":1752224335,"startTime":"0","endTime":"0","summary":"证券之星消息，7月11日华森制药发生大宗交易，交易数据如下：近三个月该股共发生25笔大宗交易，合计成交3.78万手，折价成交25笔。该股近期无解禁股上市。截至2025年7月11日收盘，华森制药(002907)报收于16.85元，上涨1.32%，换手率3.33%，成交量10.28万手，成交额1.73亿元。该股近半年内有股东持股变动，合计净减持1021.56万股，股东增减持明细如下表：该股最近90天内无机构评级。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071100027193.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002907","BK0239"],"gpt_icon":0},{"id":"2550913644","title":"华森制药：7月10日召开分析师会议，安信基金参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2550913644","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550913644?lang=zh_cn&edition=full","pubTime":"2025-07-10 19:02","pubTimestamp":1752145374,"startTime":"0","endTime":"0","summary":"证券之星消息，2025年7月10日华森制药发布公告称公司于2025年7月10日召开分析师会议，安信基金研究员 刘潇参与。截至目前公司已申请专利 35项,包括 PCT专利 17项,已公开专利 29项，授权 9项。华森制药2025年一季报显示，公司主营收入2.39亿元，同比上升4.62%；归母净利润4035.52万元，同比上升0.01%；扣非净利润3766.74万元，同比上升1.08%；负债率12.95%，投资收益-81.13万元，财务费用-453.63万元，毛利率59.22%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071000031599.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002907","BK0239"],"gpt_icon":0},{"id":"2550124746","title":"7月10日华森制药现3笔折价10.7%的大宗交易 合计成交600.09万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550124746","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550124746?lang=zh_cn&edition=full","pubTime":"2025-07-10 16:56","pubTimestamp":1752137811,"startTime":"0","endTime":"0","summary":"证券之星消息，7月10日华森制药发生大宗交易，交易数据如下：近三个月该股共发生22笔大宗交易，合计成交3.38万手，折价成交22笔。该股近期无解禁股上市。截至2025年7月10日收盘，华森制药(002907)报收于16.63元，上涨0.79%，换手率2.44%，成交量7.55万手，成交额1.26亿元。该股近半年内有股东持股变动，合计净减持1021.56万股，股东增减持明细如下表：该股最近90天内无机构评级。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025071000026363.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002907","BK0239"],"gpt_icon":0},{"id":"2549156517","title":"华森制药7月8日现2笔大宗交易 总成交金额474.23万元 其中机构买入474.23万元 溢价率为-10.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549156517","media":"新浪证券-红岸工作室","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549156517?lang=zh_cn&edition=full","pubTime":"2025-07-08 17:00","pubTimestamp":1751965200,"startTime":"0","endTime":"0","summary":" 7月8日，华森制药收涨0.60%，收盘价为16.72元，发生2笔大宗交易，合计成交量31.7万股，成交金额474.23万元。 第1笔成交价格为14.96元，成交16.70万股，成交金额249.83万元，溢价率为-10.53%，买方营业部为机构专用，卖方营业部为华泰证券股份有限公司重庆江北嘴证券营业部。 进一步统计，近3个月内该股累计发生19笔大宗交易，合计成交金额为4462.37万元。该股近5个交易日累计下跌1.18%，主力资金合计净流出3287.54万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2025-07-08/doc-infetywk3415972.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["002907","BK0239"],"gpt_icon":0},{"id":"2548861075","title":"华森制药(002907.SZ)：CX001缓释片获得药物临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2548861075","media":"智通财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548861075?lang=zh_cn&edition=full","pubTime":"2025-07-02 16:46","pubTimestamp":1751445976,"startTime":"0","endTime":"0","summary":"智通财经APP讯，华森制药 发布公告，公司于近日收到国家药品监督管理局核准签发的《药物临床试验批准通知书》。经审查，2025年4月16日受理的CX001缓释片临床试验申请符合药品注册的有关要求，同意本品开展“用于治疗带状疱疹后神经痛”适应症的临床试验。CX001缓释片为公司自研产品，将速释制剂改良为缓释制剂，该缓释制剂可降低给药频率、增加患者顺应性、提高睡眠质量。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1313026.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1583","BK0239","002907","BK1576","03347","BK1141"],"gpt_icon":0},{"id":"2548072021","title":"华森制药7月1日现1笔大宗交易 总成交金额209.86万元 其中机构买入209.86万元 溢价率为-11.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548072021","media":"新浪证券-红岸工作室","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548072021?lang=zh_cn&edition=full","pubTime":"2025-07-01 17:00","pubTimestamp":1751360400,"startTime":"0","endTime":"0","summary":" 7月1日，华森制药收涨1.62%，收盘价为16.92元，发生1笔大宗交易，合计成交量14万股，成交金额209.86万元。 第1笔成交价格为14.99元，成交14.00万股，成交金额209.86万元，溢价率为-11.41%，买方营业部为机构专用，卖方营业部为华泰证券股份有限公司重庆江北嘴证券营业部。 进一步统计，近3个月内该股累计发生17笔大宗交易，合计成交金额为3988.14万元。该股近5个交易日累计上涨2.30%，主力资金合计净流出109.67万元。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/ggzz/2025-07-01/doc-infcyiih6603719.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["002907","BK0239"],"gpt_icon":0},{"id":"2547217058","title":"重庆华森制药股份有限公司药品申请临床试验默示许可获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2547217058","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547217058?lang=zh_cn&edition=full","pubTime":"2025-06-30 11:51","pubTimestamp":1751255514,"startTime":"0","endTime":"0","summary":"6月30日，据CDE官网消息，重庆华森制药股份有限公司联合申请药品“CX001缓释片”，获得临床试验默示许可，受理号CXHL2500392。公示信息显示，药品“CX001缓释片”适应症：本品用于治疗带状疱疹后神经痛。重庆华森制药股份有限公司，成立于1996年，位于重庆市，是一家以从事医药制造业为主的企业。企业注册资本41759.6314万人民币，实缴资本7770万人民币。通过天眼查大数据分析，重庆华森制药股份有限公司共对外投资了12家企业，参与招投标项目4210次，知识产权方面有商标信息204条，专利信息134条，此外企业还拥有行政许可210个。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/06/30115151383088.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1141","03347","BK1583","BK1576","002907","BK0239"],"gpt_icon":0},{"id":"2546678891","title":"华森制药：6月26日召开分析师会议，上海谦璞投资管理有限公司参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2546678891","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546678891?lang=zh_cn&edition=full","pubTime":"2025-06-26 17:06","pubTimestamp":1750928785,"startTime":"0","endTime":"0","summary":"证券之星消息，2025年6月26日华森制药发布公告称公司于2025年6月26日召开分析师会议，上海谦璞投资管理有限公司总经理、基金经理 陈实 研究员 吴舜禹参与。2024 年公司重点中成药八味芪龙颗粒和六味安神胶囊获批国家首家中药二级保护品种，为两款产品延迟 7 年保护期。另外，公司计划在今年底之前与明年第一季度分别提交另外两个项目的 IND申请。目前仿制药在研管线研发目标是参与首轮集采，新产品的不断上市会为公司带来新的营收。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025062600026928.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002907","BK0239"],"gpt_icon":0},{"id":"2545285672","title":"华森制药收盘上涨1.47%，滚动市盈率90.01倍，总市值69.07亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545285672","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545285672?lang=zh_cn&edition=full","pubTime":"2025-06-24 18:08","pubTimestamp":1750759735,"startTime":"0","endTime":"0","summary":"6月24日，华森制药今日收盘16.54元，上涨1.47%，滚动市盈率PE达到90.01倍，总市值69.07亿元。从行业市盈率排名来看，公司所处的中药行业市盈率平均38.19倍，行业中值28.26倍，华森制药排名第59位。截至2025年一季报，共有4家机构持仓华森制药，其中其他3家、保险1家，合计持股数18528.17万股，持股市值24.66亿元。重庆华森制药股份有限公司的主营业务是中成药、化学药的研发、生产和销售。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/06/24180851272471.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0239","002907"],"gpt_icon":0},{"id":"2545948244","title":"6月23日华森制药现3笔折价10.98%的大宗交易 合计成交650.05万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545948244","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545948244?lang=zh_cn&edition=full","pubTime":"2025-06-23 17:09","pubTimestamp":1750669794,"startTime":"0","endTime":"0","summary":"证券之星消息，6月23日华森制药发生大宗交易，交易数据如下：近三个月该股共发生6笔大宗交易，合计成交1.01万手，折价成交6笔。该股近期无解禁股上市。截至2025年6月23日收盘，华森制药(002907)报收于16.3元，上涨1.12%，换手率2.48%，成交量7.66万手，成交额1.24亿元。该股近半年内有股东持股变动，合计净减持1140.28万股，股东增减持明细如下表：该股最近90天内无机构评级。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025062300020925.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002907"],"gpt_icon":0},{"id":"2544270311","title":"华森制药：6月19日高管彭晓燕减持股份合计3300股","url":"https://stock-news.laohu8.com/highlight/detail?id=2544270311","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544270311?lang=zh_cn&edition=full","pubTime":"2025-06-20 21:01","pubTimestamp":1750424513,"startTime":"0","endTime":"0","summary":"证券之星消息，根据6月20日市场公开信息、上市公司公告及交易所披露数据整理，华森制药（002907）最新董监高及相关人员股份变动情况：2025年6月19日公司高管彭晓燕共减持公司股份3300.0股，占公司总股本为0.0008%。变动期间公司股价下跌2.23%，6月19日当日收盘报16.25元。华森制药近半年内的董监高及核心技术人员增减持详情如下：华森制药的高管列表及最新持股情况如下：该股最近90天内无机构评级。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025062000036736.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002907","BK0239"],"gpt_icon":0},{"id":"2543622820","title":"6月16日华森制药现1笔折价11.69%的大宗交易 合计成交400.13万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2543622820","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543622820?lang=zh_cn&edition=full","pubTime":"2025-06-16 17:08","pubTimestamp":1750064920,"startTime":"0","endTime":"0","summary":"证券之星消息，6月16日华森制药发生大宗交易，交易数据如下：大宗交易成交价格15.63元，相对当日收盘价折价11.69%，成交25.6万股，成交金额400.13万元，买方营业部为机构专用，卖方营业部为华泰证券股份有限公司重庆江北嘴证券营业部。近三个月该股共发生3笔大宗交易，合计成交5640.0手，折价成交3笔。截至2025年6月16日收盘，华森制药报收于17.7元，上涨1.9%，换手率3.72%，成交量11.5万手，成交额2.02亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061600020939.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002907"],"gpt_icon":0},{"id":"2542586343","title":"6月10日华森制药发布公告，股东减持334.83万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2542586343","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542586343?lang=zh_cn&edition=full","pubTime":"2025-06-10 22:31","pubTimestamp":1749565917,"startTime":"0","endTime":"0","summary":"证券之星消息，6月10日华森制药发布公告《华森制药:关于控股股东及其一致行动人持股变动触及1%整数倍的公告》，其股东成都地方建筑机械化工程有限公司于2025年6月6日至2025年6月9日间合计减持334.83万股，占公司目前总股本的0.8018%，变动期间该股股价下跌5.77%，截止6月9日收盘报18.28元。股东增减持详情见下表：根据华森制药2025年一季报公布的十大股东详情如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061000037953.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002907","BK0239"],"gpt_icon":0},{"id":"2542802639","title":"6月9日华森制药现2笔折价11%的大宗交易 合计成交501.12万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542802639","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542802639?lang=zh_cn&edition=full","pubTime":"2025-06-09 17:11","pubTimestamp":1749460267,"startTime":"0","endTime":"0","summary":"证券之星消息，6月9日华森制药发生大宗交易，交易数据如下：近三个月该股共发生2笔大宗交易，合计成交3080.0手，折价成交2笔。该股近期无解禁股上市。截至2025年6月9日收盘，华森制药(002907)报收于18.28元，上涨1.11%，换手率12.13%，成交量37.46万手，成交额6.89亿元。该股近半年内有股东持股变动，合计净减持805.45万股，股东增减持明细如下表：该股最近90天内无机构评级。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025060900021641.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002907"],"gpt_icon":0},{"id":"2541346518","title":"华森制药收盘下跌6.80%，滚动市盈率98.39倍，总市值75.50亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2541346518","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2541346518?lang=zh_cn&edition=full","pubTime":"2025-06-06 16:43","pubTimestamp":1749199437,"startTime":"0","endTime":"0","summary":"6月6日，华森制药今日收盘18.08元，下跌6.80%，滚动市盈率PE达到98.39倍，总市值75.50亿元。从行业市盈率排名来看，公司所处的中药行业市盈率平均38.94倍，行业中值29.77倍，华森制药排名第60位。资金流向方面，6月6日，华森制药主力资金净流出3325.51万元，近5日总体呈流出状态，5日共流出13417.52万元。重庆华森制药股份有限公司的主营业务是中成药、化学药的研发、生产和销售。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2025/06/06164350905914.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["002907","BK0239"],"gpt_icon":0},{"id":"2540763287","title":"华森制药最新公告：目前经营情况正常 不存在应披露而未披露的重大事项","url":"https://stock-news.laohu8.com/highlight/detail?id=2540763287","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540763287?lang=zh_cn&edition=full","pubTime":"2025-06-02 15:50","pubTimestamp":1748850628,"startTime":"0","endTime":"0","summary":"经核实，公司前期所披露的信息不存在需要更改、补充之处，未发现近期公共媒体报道了可能或已经对公司股票交易价格产生较大影响的未公开重大信息，生产经营情况正常，内外部经营环境未发生重大变化，公司、控股股东和实际控制人不存在关于公司的应披露而未披露的重大事项，或处于筹划阶段的重大事项。公司不存在违反信息公平披露的情形。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025060200001524.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002907"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1752868892968,"stockEarnings":[{"period":"1week","weight":0.0303},{"period":"1month","weight":0.0445},{"period":"3month","weight":0.3359},{"period":"6month","weight":0.4106},{"period":"1year","weight":0.4193},{"period":"ytd","weight":0.339}],"compareEarnings":[{"period":"1week","weight":0.0069},{"period":"1month","weight":0.043},{"period":"3month","weight":0.0787},{"period":"6month","weight":0.0903},{"period":"1year","weight":0.1872},{"period":"ytd","weight":0.0545}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"重庆华森制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"27712人(较上一季度增加6.36%)","perCapita":"11146股","listingDate":"2017-10-20","address":"重庆市荣昌区工业园区","registeredCapital":"41759万元","survey":" 重庆华森制药股份有限公司的主营业务是中成药、化学药的研发、生产和销售。公司的主要产品是甘桔冰梅片、都梁软胶囊、六味安神胶囊、八味芪龙颗粒、痛泻宁颗粒、威地美（铝碳酸镁片）、铝碳酸镁咀嚼片、长松（聚乙二醇4000散）、胆舒软胶囊、注射用甲磺酸加贝酯、注射用奥美拉唑钠、上清片、融通（注射用阿魏酸钠）、西洛他唑片、卡托普利片、水王（螺旋藻胶囊）、阿昔洛韦片、甲硝唑片等。","listedPrice":4.53},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"华森制药(002907)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供华森制药(002907)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"华森制药,002907,华森制药股票,华森制药股票老虎,华森制药股票老虎国际,华森制药行情,华森制药股票行情,华森制药股价,华森制药股市,华森制药股票价格,华森制药股票交易,华森制药股票购买,华森制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"华森制药(002907)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供华森制药(002907)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}